← All Posts
Eli Lilly and Company
May 05, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
Election of the following directors, each to serve a three-year term |
|
| 1a |
Carolyn Bertozzi |
✓ For(13.915)
|
| 1b |
William Kaelin, Jr. |
✓ For(13.915)
|
| 1c |
Jon Moeller |
✓ For(13.915)
|
| 1d |
David Ricks |
✗ Against(13.915)
|
| 2 |
Approval, on an advisory basis, of the compensation paid to the company's named executive officers. |
✓ For(13.915)
|
| 3 |
Ratification of the appointment of Ernst & Young LLP as the independent auditor for 2026. |
✓ For(13.915)
|
| 4 |
Approval of amendments to the company's articles of incorporation to eliminate the classified board structure. |
✓ For(13.915)
|
| 5 |
Approval of amendments to the company's articles of incorporation to eliminate supermajority voting provisions. |
✓ For(13.915)
|
| 6 |
Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. |
✓ For(13.915)
|
| 7 |
Shareholder proposal to prepare an annual lobbying report. |
✓ For(13.915)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.